A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.
Bora J, Dey A, Lyngdoh AR, Dhasmana A, Ranjan A, Kishore S, Rustagi S, Tuli HS, Chauhan A, Rath P, Malik S.
Bora J, et al. Among authors: rath p.
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3459-3481. doi: 10.1007/s00210-023-02631-1. Epub 2023 Jul 31.
Naunyn Schmiedebergs Arch Pharmacol. 2023.
PMID: 37522916
Review.